Evidence map›Paper›PMID 38994565›Full record

ArticleNucleic acids research2024

EcCas6e-based antisense crRNA for gene repression and RNA editing in microorganisms.

Mutong Li, Zhaohui Cai, Shucheng Song, Xinmin Yue, Wenyu Lu, Shuquan Rao, Chuanbo Zhang, Chaoyou Xue

Abstract read
In one paragraph

Article in Nucleic acids research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mutong LiSchool of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China.
Zhaohui CaiKey Laboratory of Engineering Biology for Low-Carbon Manufacturing, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China.
Shucheng SongCollege of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China.
Xinmin YueKey Laboratory of Engineering Biology for Low-Carbon Manufacturing, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China.
Wenyu LuSchool of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China.ORCID 0000-0002-3093-3990
Shuquan RaoState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
Chuanbo ZhangSchool of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China.
Chaoyou XueKey Laboratory of Engineering Biology for Low-Carbon Manufacturing, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China.ORCID 0000-0002-5323-6178

Funding

CAMS Innovation Fund for Medical Sciences (CIFMS) 2021-I2M-1-041Chinese Academy of Medical Sciences 2021-RC310-015Haihe Laboratory 22HHSWSS00024National Key R&D Program of China 2023YFC3402301National Natural Science Foundation of China 32101203Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project TSBICIP-CXRC-025
6 · The paper itself

Abstract

Precise gene regulation and programmable RNA editing are vital RNA-level regulatory mechanisms. Gene repression tools grounded in small non-coding RNAs, microRNAs, and CRISPR-dCas proteins, along with RNA editing tools anchored in Adenosine Deaminases acting on RNA (ADARs), have found extensive application in molecular biology and cellular engineering. Here, we introduced a novel approach wherein we developed an EcCas6e mediated crRNA-mRNA annealing system for gene repression in Escherichia coli and RNA editing in Saccharomyces cerevisiae. We found that EcCas6e possesses inherent RNA annealing ability attributed to a secondary positively charged cleft, enhancing crRNA-mRNA hybridization and stability. Based on this, we demonstrated that EcCas6e, along with its cognate crRNA repeat containing a complementary region to the ribosome binding site of a target mRNA, effectively represses gene expression up to 25-fold. Furthermore, we demonstrated that multiple crRNAs can be easily assembled and can simultaneously target up to 13 genes. Lastly, the EcCas6e-crRNA system was developed as an RNA editing tool by fusing it with the ADAR2 deaminase domain. The EcCas6e-crRNA mediated gene repression and RNA editing tools hold broad applications for research and biotechnology.

Indexed as

Escherichia coliRNA, AntisenseRNA EditingRNA, MessengerSaccharomyces cerevisiaeAdenosine DeaminaseCRISPR-Associated ProteinsCRISPR-Cas SystemsRNA-Binding ProteinsAdenosine DeaminaseCRISPR-Associated ProteinsRNA, AntisenseRNA-Binding ProteinsRNA, Messenger

Identifiers

PMID38994565
PMCPMC11317134

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.